According to the latest report by IMARC Group, titled “Gastrointestinal Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global gastrointestinal therapeutics market size reached a strong growth in 2020. Gastrointestinal, or GI, disorder refers to medical conditions related to the digestive system. These diseases affect the rectum, colon, small and large intestines, gall bladder, liver, and stomach. GI disorders are characterized by various symptoms, such as bloating, pain, nausea, diarrhea, heartburn, and constipation. Gastrointestinal drugs are prescribed based on endoscopy, blood tests, and imaging tests. There are various GI therapeutics available targeted at providing relief and minimizing gastric acidity. Some of the common therapeutics include prescription and over-the-counter (OTC) drugs, such as Afinitor, Dificid, antacids, laxatives, and Aciphex.
Request Free Sample Report: https://www.imarcgroup.com/gastrointestinal-therapeutics-market/requestsample
The global GI therapeutics market is primarily being driven by the increasing prevalence of GI diseases, such as ulcerative colitis, peptic ulcer diseases, and irritable bowel syndrome. In addition to this, the rising geriatric population, which is more prone to GI ailments, is further supporting the market growth. Moreover, the development of cellular therapies and innovative biosimilars for the treatment of GI disorders is also contributing to the growth of the market. Rising health consciousness amongst consumers, improvements in healthcare infrastructure, and innovations in research and development (R&D) activities are some of the factors driving the GI therapeutics market further toward growth. Looking forward, IMARC Group expects the global gastrointestinal therapeutics market to exhibit moderate growth during 2021-2026.
Breakup by Type:
Breakup by Route of Administration:
Breakup by Application:
- Ulcerative Colitis
- Crohn’s Disease
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Competitive Landscape with Key Player:
- Abbott Laboratories
- AbbVie Inc.
- AstraZeneca Plc
- Bausch Health Companies Inc.
- Bayer Aktiengesellschaft
- GlaxoSmithKline Plc
- Janssen Biotech Inc. (Johnson & Johnson)
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi S.A.
- Takeda Pharmaceuticals
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/gastrointestinal-therapeutics-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
We are updating our reports, If you want to need latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter: @imarcglobal
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Address:30 N Gould St 30 N Gould St
Country: United States